心脏骤停对梗死相关心源性休克 culprit 病变干预结局的影响
基于 CULPRIT-SHOCK 随机试验与注册研究,分析 1015 例梗死相关心源性休克患者,其中 550 例(54.2%)发生心脏骤停。心脏骤停是 1 年死亡独立预测因素(HR 1.27;95%CI 1.01-1.59),但无论是否心脏骤停,仅处理 culprit 病变 PCI 均优于立即多支 PCI(交互 P=0.6)。
要点
- 梗死相关心源性休克患者中超半数(54.2%)发生心脏骤停
- 心脏骤停者更年轻、合并症更少但器官灌注受损体征更多
- 无论是否心脏骤停,仅 culprit 病变 PCI 为优选策略
核心结论
- 心脏骤停是梗死相关心源性休克患者 1 年死亡的独立预测因素(HR 1.27;95%CI 1.01-1.59)。
- 仅 culprit 病变 PCI 在心脏骤停与非心脏骤停患者中均优于立即多支 PCI(交互 P=0.6)。
研究设计与样本
- 基于 CULPRIT-SHOCK 随机试验与注册研究,分析 1015 例梗死相关心源性休克患者,按是否心脏骤停分层。
- 主要评估 30 天内全因死亡或需肾脏替代治疗的严重肾衰竭,以及 1 年死亡。
主要发现
- 550 例(54.2%)患者发生心脏骤停。
- 心脏骤停患者更年轻、男性更多,外周动脉疾病、肾小球滤过率<30 mL/min 及左主干病变比例更低,器官灌注受损体征更常见。
- 30 天内全因死亡或严重肾衰竭:心脏骤停组 51.2% vs 非心脏骤停组 48.5%(P=0.39)。
- 1 年死亡:心脏骤停组 53.8% vs 非心脏骤停组 50.4%(P=0.29)。
关键数值与推荐
- 30 天内全因死亡或严重肾衰竭复合终点:心脏骤停组 51.2% vs 非心脏骤停组 48.5%(P=0.39)。
- 1 年死亡:心脏骤停组 53.8% vs 非心脏骤停组 50.4%(P=0.29)。
- 多因素分析中心脏骤停预测 1 年死亡 HR 1.27(95%CI 1.01-1.59)。
- 随机试验中仅 culprit 病变 PCI 与立即多支 PCI 的交互作用 P=0.6。
临床怎么用
- 对梗死相关心源性休克合并心脏骤停患者,应识别其 1 年死亡风险增高。
- 无论是否合并心脏骤停,优先采用仅处理 culprit 病变的 PCI 策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac arrest (CA) is common in patients with infarct-related cardiogenic shock (CS). OBJECTIVES: The goal of this study was to identify the characteristics and outcomes of culprit lesion percutaneous coronary intervention (PCI) of patients with infarct-related CS stratified according to CA in the CULPRIT-SHOCK (Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock) randomized trial and registry. METHODS: Patients with CS with and without CA from the CULPRIT-SHOCK study were analyzed. All-cause death or severe renal failure leading to renal replacement therapy within 30 days and 1-year death were assessed. RESULTS: Among 1,015 patients, 550 (54.2%) had CA. Patients with CA were younger, more frequently male, had lower rates of peripheral artery disease, a glomerular filtration rate <30 mL/min, and left main disease, and they presented more often with clinical signs of impaired organ perfusion. The composite of all-cause death or severe renal failure within 30 days occurred in 51.2% of patients with CA vs 48.5% in non-CA patients (P = 0.39) and 1-year death in 53.8% vs 50.4% (P = 0.29), respectively. In a multivariate analysis, CA was an independent predictor of 1-year mortality (HR: 1.27; 95% CI: 1.01-1.59). In the randomized trial, culprit lesion-only PCI was superior to immediate multivessel PCI in patients both with and without CA (P for interaction = 0.6). CONCLUSIONS: More than 50% of patients with infarct-related CS had CA. These patients with CA were younger and had fewer comorbidities, but CA was an independent predictor of 1-year mortality. Culprit lesion-only PCI is the preferred strategy, both in patients with and without CA. (Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock [CULPRIT-SHOCK]; NCT01927549).
引用
- Zeymer, Alushi, Noc, et al. Influence of Culprit Lesion Intervention on Outcomes in Infarct-Related Cardiogenic Shock With Cardiac Arrest. J Am Coll Cardiol. 2023. PMID: 36948733. doi:10.1016/j.jacc.2023.01.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。